Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EEV3 | ISIN: US4268973025 | Ticker-Symbol: 336
München
28.03.24
08:05 Uhr
2,260 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
HEPION PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
HEPION PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur HEPION PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.03.Hepion Pharmaceuticals Inc expected to post a loss of $2.63 a share - Earnings Preview1
15.03.Hepion Pharmaceuticals Inc expected to post a loss of $2.63 a share - Earnings Preview1
08.03.Hepion Pharmaceuticals Inc expected to post a loss of $2.63 a share - Earnings Preview2
06.03.Hepion Pharmaceuticals, Inc. - 8-K, Current Report1
06.03.Hepion Pharmaceuticals expands board with new director1
06.03.Hepion Pharmaceuticals, Inc.: Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell397EDISON, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on therapeutic drug development for the treatment of...
► Artikel lesen
16.02.Hepion Pharmaceuticals, Inc. - 8-K, Current Report2
16.02.Hepion announces exercise of warrants for about $2M gross proceeds2
16.02.Hepion Pharmaceuticals exercises warrant, secures $2 million1
16.02.Hepion Pharmaceuticals, Inc.: Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds2
13.02.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 44.200The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS42328V8019 HELIUS...
► Artikel lesen
07.02.Hepion Pharmaceuticals, Inc. - 8-K, Current Report4
03.01.Hepion Pharmaceuticals, Inc.: Hepion Pharmaceuticals to Present at NASH-TAG 20246
03.01.Hepion Pharmaceuticals, Inc. - 8-K, Current Report1
07.12.23Hepion's NASH trial hangs in the balance as biotech cuts costs by 60%, CEO departs6
07.12.23Hepion Pharma announces restructuring plan, sees $400-800 thousand charge for 4Q3
07.12.23Hepion Pharmaceuticals, Inc. - 8-K, Current Report1
07.12.23Hepion Pharmaceuticals, Inc.: Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes199Restructuring program purpose is to preserve capital and optimize clinical development program Management plans to continue to evaluate its Phase 2b ASCEND-NASH clinical trial taking in account current...
► Artikel lesen
28.11.23Hepion Pharmaceuticals, Inc.: Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit2
28.11.23Hepion Pharmaceuticals says Wijngaard buys 5K shares in co2
Seite:  Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1